不断加码！

Group 1 - The core viewpoint of the news is that QDII funds are experiencing increased restrictions on large subscriptions, with many funds lowering their maximum subscription limits significantly [1][2][3] - Several QDII funds have adjusted their large subscription limits, with the maximum now set as low as 500 yuan, indicating a trend of tightening access to these investment vehicles [2][5] - The adjustment in subscription limits is aimed at protecting the interests of fund shareholders, as seen in the case of the Hua Bao Overseas Technology Stock Fund, which reduced its daily subscription limit to 1,000 yuan [3][4] Group 2 - The performance of QDII funds has been strong this year, with many funds showing positive net asset value growth, which has attracted significant inflows [6][7] - Notable performers include the Huatai-PineBridge Hang Seng Innovation Drug ETF and the GF CSI Hong Kong Innovation Drug ETF, both of which have achieved returns exceeding 85% this year [7] - Market analysts suggest that the tightening of QDII fund subscriptions may be a response to the strong performance and increased investor interest, as funds like the Huatai-PineBridge Hong Kong Advantage Selection have seen a net value growth rate of over 135% [6][8]